Compile Data Set for Download or QSAR
Found 778 with Last Name = 'wang' and Initial = 'xm'
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204382(US9242996, 461)copy SMILEScopy InChI
Affinity DataIC50: 0.00431nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204241(US9242996, 315)copy SMILEScopy InChI
Affinity DataIC50: 0.00500nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204384(US9242996, 463)copy SMILEScopy InChI
Affinity DataIC50: 0.00550nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204469(US9242996, 179)copy SMILEScopy InChI
Affinity DataIC50: 0.00612nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204281(US9242996, 360)copy SMILEScopy InChI
Affinity DataIC50: 0.00665nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204470(US9242996, 180)copy SMILEScopy InChI
Affinity DataIC50: 0.00671nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204316(US9242996, 395)copy SMILEScopy InChI
Affinity DataIC50: 0.00827nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204294(US9242996, 373)copy SMILEScopy InChI
Affinity DataIC50: 0.00837nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204168(US9242996, 242)copy SMILEScopy InChI
Affinity DataIC50: 0.00875nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204405(US9242996, 478a)copy SMILEScopy InChI
Affinity DataIC50: 0.00900nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204301(US9242996, 380)copy SMILEScopy InChI
Affinity DataIC50: 0.00970nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204270(US9242996, 344)copy SMILEScopy InChI
Affinity DataIC50: 0.00977nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204308(US9242996, 387)copy SMILEScopy InChI
Affinity DataIC50: 0.0100nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204255(US9242996, 329)copy SMILEScopy InChI
Affinity DataIC50: 0.0100nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204274(US9242996, 353)copy SMILEScopy InChI
Affinity DataIC50: 0.0103nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204496(US9242996, 206)copy SMILEScopy InChI
Affinity DataIC50: 0.0104nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204303(US9242996, 382)copy SMILEScopy InChI
Affinity DataIC50: 0.0107nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204269(US9242996, 343)copy SMILEScopy InChI
Affinity DataIC50: 0.0110nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204471(US9242996, 181)copy SMILEScopy InChI
Affinity DataIC50: 0.0119nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204169(US9242996, 243)copy SMILEScopy InChI
Affinity DataIC50: 0.0121nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204185(US9242996, 259)copy SMILEScopy InChI
Affinity DataIC50: 0.0127nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204264(US9242996, 338)copy SMILEScopy InChI
Affinity DataIC50: 0.0139nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204479(US9242996, 189)copy SMILEScopy InChI
Affinity DataIC50: 0.0139nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204188(US9242996, 262)copy SMILEScopy InChI
Affinity DataIC50: 0.0140nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204262(US9242996, 336)copy SMILEScopy InChI
Affinity DataIC50: 0.0143nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204278(US9242996, 357)copy SMILEScopy InChI
Affinity DataIC50: 0.0143nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204315(US9242996, 394)copy SMILEScopy InChI
Affinity DataIC50: 0.0153nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204193(US9242996, 267)copy SMILEScopy InChI
Affinity DataIC50: 0.0158nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204187(US9242996, 261)copy SMILEScopy InChI
Affinity DataIC50: 0.0168nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204268(US9242996, 342)copy SMILEScopy InChI
Affinity DataIC50: 0.0173nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204272(US9242996, 346)copy SMILEScopy InChI
Affinity DataIC50: 0.0175nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204480(US9242996, 190)copy SMILEScopy InChI
Affinity DataIC50: 0.0176nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204297(US9242996, 376)copy SMILEScopy InChI
Affinity DataIC50: 0.0183nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204458(US9242996, 133)copy SMILEScopy InChI
Affinity DataIC50: 0.0187nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204386(US9242996, 465)copy SMILEScopy InChI
Affinity DataIC50: 0.0187nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204275(US9242996, 354)copy SMILEScopy InChI
Affinity DataIC50: 0.0194nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204183(US9242996, 257)copy SMILEScopy InChI
Affinity DataIC50: 0.0197nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204317(US9242996, 396)copy SMILEScopy InChI
Affinity DataIC50: 0.0198nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204166(US9242996, 240)copy SMILEScopy InChI
Affinity DataIC50: 0.0199nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204335(US9242996, 414)copy SMILEScopy InChI
Affinity DataIC50: 0.0200nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204329(US9242996, 408)copy SMILEScopy InChI
Affinity DataIC50: 0.0201nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204295(US9242996, 374)copy SMILEScopy InChI
Affinity DataIC50: 0.0205nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204279(US9242996, 358)copy SMILEScopy InChI
Affinity DataIC50: 0.0205nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204286(US9242996, 365)copy SMILEScopy InChI
Affinity DataIC50: 0.0208nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204261(US9242996, 335)copy SMILEScopy InChI
Affinity DataIC50: 0.0208nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204186(US9242996, 260)copy SMILEScopy InChI
Affinity DataIC50: 0.0208nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204159(US9242996, 233)copy SMILEScopy InChI
Affinity DataIC50: 0.0209nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204302(US9242996, 381)copy SMILEScopy InChI
Affinity DataIC50: 0.0209nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204464(US9242996, 174)copy SMILEScopy InChI
Affinity DataIC50: 0.0210nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM204520(US9242996, 350)copy SMILEScopy InChI
Affinity DataIC50: 0.0217nMpH: 7.5Assay Description:Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XP73RNUS Patent
Displayed 1 to 50 (of 778 total ) | Next | Last >>
Jump to: